Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 71 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Immune Response to Antigens

    Jacksonville, FL

  2. A Study to Assess Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally-advanced Breast Cancer

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate the Safety of the Goldilocks Procedure with Implant-Based Reconstruction

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  6. Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment

    Scottsdale/Phoenix, AZ

  7. Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study

    Rochester, MN

  8. Long-term Follow Up of Patients Previously Enrolled in MC1137 (BEAUTY)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease

    Rochester, MN, Jacksonville, FL

  10. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer